[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340434-105":59,"doc-detail-340434-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","biomarkers-in-colorectal-cancer-actual-and-future-perspectives-review","Biomarkers in Colorectal Cancer: Actual and Future Perspectives - Review","","Biomarkers in colorectal cancer (CRC) attract major research attention as liquid biopsy and next-generation sequencing (NGS) improve analytic capability. Global screening strategies differ, with multi-target stool DNA (mt-sDNA) widely used in the USA and Cologuard Plus increasingly implemented. Early detection potential is highlighted for Galectins and septins, while gut microbiome signals such as Fusobacterium nucleatum are actively investigated. Diagnostic performance is assessed across circulating DNA (via NGS) and emerging circulating tumor cells, alongside guideline-supported predictive biomarkers, and future enhancement through machine learning and artificial intelligence.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/biomarkers-in-colorectal-cancer-actual-and-future-perspectives-review/340434/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/biomarkers-in-colorectal-cancer-actual-and-future-perspectives-review/340434.png","ImageObject",300,407,{"name":92,"@type":93},"Quinn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are biomarkers in colorectal cancer an important research focus?","Question",{"text":112,"@type":113},"They are central to current literature because advances such as liquid biopsy and next-generation sequencing (NGS) enable more effective biomarker characterization for screening, diagnosis, and prognosis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which biomarkers and screening approaches are emphasized in the review’s abstract?",{"text":117,"@type":113},"The abstract highlights multi-target stool DNA (mt-sDNA) used in the USA (including Cologuard Plus), Galectins and septins for early detection, and gut microbiome assessment such as Fusobacterium nucleatum.",{"name":119,"@type":110,"acceptedAnswer":120},"What future directions does the review mention for improving biomarkers?",{"text":121,"@type":113},"It notes that guideline-based predictive biomarkers may be improved using machine learning and artificial intelligence, and it discusses emerging diagnostic options like circulating tumor cells as alternatives to traditional methods.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340434,1790669608,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Review  \nBiomarkers in Colorectal Cancer: Actual and Future Perspectives  \nHoria-Dan Lis, cu 1,2, Nicolae Verga 2, Dimitrie-Ionu Atasiei 1, *, Dumitru-Cristinel Badiu 3, Adrian Vasile Dumitru 4, Flavia Ultimescu 5, Christopher Pavel 6, Roxana-Elena Stefan 7,  \nDiandra-Carmen Manole 8 and Andreea-Iuliana Ionescu 1,2  \nCitation: Lis, cu, H.-D.; Verga, N.; Atasiei, D.-I.; Badiu, D.-C.; Dumitru, A.V.; Ultimescu, F.; Pavel, C.; Stefan, R.-E.; Manole, D.-C.; Ionescu, A.-I. Biomarkers in Colorectal Cancer:  \nActual and Future Perspectives. Int. J. Mol. Sci. 2024, 25, 11535. [https://](https://)[ ](https://)[doi.org/10.3390/ijms252111535](doi.org/10.3390/ijms252111535)  \nAcademic Editors: Stergios Boussiosand Matin Sheriff  \nReceived: 4 October 2024  \nRevised: 23 October 2024  \nAccepted: 24 October 2024  \nPublished: 27 October 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Discipline of Oncological Radiotherapy and Medical Imaging, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania; [horia-dan.liscu@drd.umfcd.ro](horia-dan.liscu@drd.umfcd.ro) (H.-D.L.);  \nandreea-iuliana.miron@drd.umfcd.ro (A.-I.I.)  \n2 Radiotherapy Department, Colea Clinical Hospital, 030167 Bucharest, Romania; [nicolae.verga@umfcd.ro](nicolae.verga@umfcd.ro)  \n3 Department of Surgery, Bagdasar Arseni Clinical Emergency Hospital, Carol Davila University of Medicine and Pharmacy, 8 Eroii Sanitari Bd., 050474 Bucharest, Romania; [dumitru.badiu@umfcd.ro](dumitru.badiu@umfcd.ro)  \n4 Department of Pathology, University Emergency Hospital Bucharest, Carol Davila University of Medicine and Pharmacy, 8 Eroii Sanitari Bd., 050474 Bucharest, Romania; [dr.adriandumitru@yahoo.com](dr.adriandumitru@yahoo.com)  \n5 Department of Pathology, Institute of Oncology Alexandru Trestioreanu, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania; [flavia.ultimescu@drd.umfcd.ro](flavia.ultimescu@drd.umfcd.ro)  \n6 Department of Gastroenterology, Floreasca Emergency Hospital Bucharest, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania; [christopher-jesse-vlad.pavel@drd.umfcd.ro](christopher-jesse-vlad.pavel@drd.umfcd.ro)  \n[7](7 General Surgery Department)[ General Surgery Department](7 General Surgery Department), [Clinic of General and Esophageal Surgery](Clinic of General and Esophageal Surgery), [Sf](Sf). Maria Clinical Hospital, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania; roxana-elena.stefan@drd.umfcd.ro  \n8 Department of Endocrinology, Faculty of General Medicine, Carol Davila University of Medicine and Pharmacy, 8 Eroii Sanitari Bd., 050474 Bucharest, Romania; [m.diandracarmen@gmail.com](m.diandracarmen@gmail.com)  \n* Correspondence: [ionut.atasiei@stud.umfcd.ro](ionut.atasiei@stud.umfcd.ro)  \nAbstract: Biomarkers in colorectal cancer (CRC) are of great interest in the current literature due to improvements in techniques such as liquid biopsy and next-generation sequencing (NGS) . However, screening methods vary globally, with multi-target stool DNA (mt-sDNA) predominantly used in the USA and, more recently, the Cologuard Plus; biomarkers such as the Galectins family and septins show promise in early detection. Gut microbiome assessments, such as Fusobacterium nucleatum, are under intense exploration. Diagnostic tests, such as circulating DNA analysis via NGS, exhibit effectiveness and are being increasingly adopted. Circulating tumor cells emerge as potential alternatives to traditional methods in terms of diagnosis and prognosis. Predictive biomarkers are well established in guidelines; nonetheless, with the aid of machine learning and artificial intelligence, the","cbCaihb64PHheWeZ","https://ap.wps.com/l/cbCaihb64PHheWeZ","pdf",1030963,"English","# Abstract\n# Keywords\n# 1. Introduction\n## Rectal cancer burden and global rankings\n## Screening trends and age-related incidence changes\n## Need for early diagnosis in asymptomatic patients","[{\"question\":\"Why are biomarkers in colorectal cancer an important research focus?\",\"answer\":\"They are central to current literature because advances such as liquid biopsy and next-generation sequencing (NGS) enable more effective biomarker characterization for screening, diagnosis, and prognosis.\"},{\"question\":\"Which biomarkers and screening approaches are emphasized in the review’s abstract?\",\"answer\":\"The abstract highlights multi-target stool DNA (mt-sDNA) used in the USA (including Cologuard Plus), Galectins and septins for early detection, and gut microbiome assessment such as Fusobacterium nucleatum.\"},{\"question\":\"What future directions does the review mention for improving biomarkers?\",\"answer\":\"It notes that guideline-based predictive biomarkers may be improved using machine learning and artificial intelligence, and it discusses emerging diagnostic options like circulating tumor cells as alternatives to traditional methods.\"}]","Biomarkers in Colorectal Cancer: Actual and Future Perspectives - Review | PDF",1790036474,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9a75b34217e9861d283e6dd3480eaa96.webp",983,1390,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b364df813561a0f3cad483faca88d496.webp",982,1388,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bcbcb0f9b653a1fbcf5a26776ccd34f1.webp",981,1387,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/948ad8cae9add3d554d1773a6d8a2f1b.webp",980,1385]